Vivani Medical, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | — | — | — | — | $3.4M |
| Cost of Revenue | — | — | — | — | — | $130.0K | $500.0K | $2.2M |
| Gross Profit | — | — | — | — | — | $130.0K | $500.0K | $1.2M |
| Gross Margin | — | — | — | — | — | — | — | 36.3% |
| Operating Expenses | ||||||||
| Research & Development | — | $18.1M | $15.7M | $17.0M | $14.2M | $11.0M | $4.8M | $13.1M |
| SG&A Expense | — | $9.4M | $8.9M | $10.0M | $7.1M | $2.3M | $5.9M | $9.2M |
| Operating Income | — | $-27.6M | $-24.7M | $-27.0M | $-21.2M | $-13.3M | $-14.9M | $-34.0M |
| Operating Margin | — | — | — | — | — | — | — | -1,004.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-26.6M | $-23.5M | — | — | — | — | — |
| Income Tax Expense | — | — | $2.0K | — | — | — | — | $0 |
| Net Income | — | $-26.6M | $-23.5M | $-25.7M | $-13.9M | $-12.8M | $-14.9M | $-33.6M |
| Net Margin | — | — | — | — | — | — | — | -994.1% |
| EPS (Basic) | — | $-0.43 | $-0.43 | $0.00 | — | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | — | $-0.43 | $-0.43 | $0.00 | — | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 84.6M | 62.4M | 55.0M | 55.0M | 54.85B | 39.78B | 25.09B | 16.91B |
| Shares Outstanding (Diluted) | 84.6M | 62.4M | 55.0M | 55.0M | 54.85B | 39.78B | 25.09B | 16.91B |
| Dividends Per Share | — | — | — | — | — | — | — | — |